Egg Farmers of Ontario invest $1 million into egg drug research

Apr 01, 2013

Egg farmers fund egg-derived depression drug solution

A new antidepressant drug derived from eggs is getting support from egg producers themselves. Egg Farmers of Ontario announced the investment of $1 million in research and development funding to United Paragon Associations to fund clinical trials for an antidepressant drug that may see eggs as part of the solution to address depression.

The new antidepressant drug called Rellidep™ is being tested as an antidepressant drug for people who are suffering from depression. Some of the key ingredients of the drug come from eggs – which has the potential to increase the production and marketing of eggs in Ontario.

The funding dollars will partially fund the second phase of clinical trials for Rellidep™. Early tests of the drug indicate that it may be more effective than current antidepressants on the market.

Egg Farmers of Ontario represents roughly 440 egg and pullet farmers in the province and operates as an industry funded organization

Video: Dr. David Rosero: Fat Quality in Swine Diets

In this episode of The Swine Nutrition Blackbelt Podcast, Dr. David Rosero from Iowa State University explores the critical aspects of fat quality and oxidation in swine diets. He discusses how different types of lipids affect pig performance and provides actionable insights on managing lipid oxidation in feed mills. Don’t miss this episode—available on all major platforms.

Highlight quote: "Increasing levels of oxidized fats in swine diets reduced the efficiency of feed utilization, increased mortality, and led to more pigs being classified as culls, reducing the number of full-value pigs entering the finishing barns."

Meet the guest: Dr. David Rosero / davidrosero is an assistant professor of animal science at Iowa State University. His research program focuses on conducting applied research on swine nutrition and the practical application of smart farming. He previously served as the technical officer for The Hanor Company, overseeing nutrition, research, and innovation efforts.